倍他司汀联合氟桂利嗪治疗椎基底动脉供血不足的临床研究

目的：观察倍他司汀联合氟桂利嗪治疗椎基底动脉供血不足的疗效。方法：将所有病例随机分为氟桂利嗪组和联合治疗组。氟桂利嗪组给予氟桂利嗪胶囊治疗；联合治疗组在此基础上给予倍他司汀口服治疗。治疗后使用经颅多普勒血流诊断系统（TCD）检测血流情况，观察两组治疗效果。结果：联合治疗组的有效率高于氟桂利嗪组，P＜0.05。两组经过治疗，血流异常情况得到改善，联合治疗组血流异常情况的改善情况要优于氟桂利嗪组，P＜0.05。结论：倍他司汀联合氟桂利嗪治疗椎基底动脉供血不足安全有效。

Betahistine combined flunarizine clinical research for the treatment of vertebral basilar artery blood supply shortage

Objective:to observe betahistine combined flunarizine curative effect for the treatment of vertebral basilar artery blood supply deficiency. Methods:all cases were randomly divided into flunarizine group and combination group. Flunarizine group was given flunarizine capsules treatment; Combined:treatment group on the basis of the given betahistine injection treatment. Using transcranial doppler blood flow after treatment diagnosis system (TCD) detection of blood flow, observe two groups of treatment effect. Results of combined treatment group effective than flunarizine group, P<0.05. After the two groups after treatment, the blood flow anomalies have been improved to a certain extent, the joint treatment group on the improvement of their blood flow abnormalities than flunarizine group, P<0.05. Conclusion:betahistine combined flunarizine vertebral basilar artery blood supply deficiency is safe and effective treatment.